Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency
نویسندگان
چکیده
Background Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a mitochondrial fatty acid oxidation disorder that causes episodic attacks, such as general fatigue, hypotonia, myalgia, and rhabdomyolysis accompanied by lack of energy. As yet, there are no preventative drugs for these VLCADD-associated metabolic attacks. Patients methods We conducted an open-label, non-randomized, multi-center study into the effects bezafibrate on five patients with VLCADD. Bezafibrate was administered 4 years, we analyzed number myopathic attacks requiring hospitalization treatment infusions. Results The infusions 24 h or longer significantly decreased during period. patients’ ability to conduct everyday activities also improved treatment. Conclusion Our findings show potential long-term efficacy in preventing
منابع مشابه
Clinical features and mutations in seven Chinese patients with very long chain acyl-CoA dehydrogenase deficiency.
BACKGROUND Very long chain acyl-CoA dehydrogenase deficiency (VLCADD) is an inherited metabolic disease caused by deleterious mutations in the ACADVL gene that encodes very long chain acyl-CoA dehydrogenase (VLCAD), and which can present as cardiomyopathy in neonates, as hypoketotic hypoglycemia in infancy, and as myopathy in late-onset patients. Although many ACADVL mutations have been describ...
متن کاملClear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.
Very-long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial rate-limiting step in mitochondrial fatty acid beta-oxidation. VLCAD deficiency is clinically heterogenous, with three major phenotypes: a severe childhood form, with early onset, high mortality, and high incidence of cardiomyopathy; a milder childhood form, with later onset, usually with hypoketotic hypoglycemia as the main p...
متن کاملA severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency.
A patient with very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is reported. He had a severe neonatal presentation and cardiomyopathy. He was found to be homozygous for a severe mutation with no residual enzyme activity. Tandem mass spectrometry on dried blood spots revealed increased long chain acylcarnitines. VLCAD enzyme activity was severely decreased to 2% of control levels. Dieta...
متن کاملH2O2 release from the very long chain acyl-CoA dehydrogenase
Enhanced mitochondrial generation of oxidants, including hydrogen peroxide (H2O2), is related to a large number of pathological conditions, including diet-induced obesity and steatohepatosis. Indeed, we have previously shown that high fat diets increase the generation of H2O2 in liver mitochondria energized by activated fatty acids. Here, we further study fatty-acid induced H2O2 release in live...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brain & Development
سال: 2021
ISSN: ['1872-7131', '0387-7604']
DOI: https://doi.org/10.1016/j.braindev.2020.07.019